Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson’s disease

Abstract excerpt

Translation of disease-modifying therapies in neurodegenerative disease has been disappointing. Parkinson's disease (PD) was used to compare patterns of preclinical study design for symptomatic and potentially disease-modifying interventions. We examined the relationship of model, intervention type and timing, outcomes and outcome measures in 543 animal and human studies (1973-2015) across a contemporary cohort...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Nerve injury and regeneration
• Share to Neuroscience and Neuropharmacology Research
• Share to Parkinson's Disease Mechanisms and Treatments